BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 21116205)

  • 1. The intraportal injection model for liver metastasis: advantages of associated bioluminescence to assess tumor growth and influences on tumor uptake of radiolabeled anti-carcinoembryonic antigen antibody.
    Frampas E; Maurel C; Thedrez P; Remaud-Le Saëc P; Faivre-Chauvet A; Barbet J
    Nucl Med Commun; 2011 Feb; 32(2):147-54. PubMed ID: 21116205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intratumoral distribution of radiolabeled antibody and radioimmunotherapy in experimental liver metastases model of nude mouse.
    Sato N; Saga T; Sakahara H; Yao Z; Nakamoto Y; Zhang M; Kuroki M; Matsuoka Y; Iida Y; Konishi J
    J Nucl Med; 1999 Apr; 40(4):685-92. PubMed ID: 10210230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microdistribution of targeted, fluorescently labeled anti-carcinoembryonic antigen antibody in metastatic colorectal cancer: implications for radioimmunotherapy.
    Fidarova EF; El-Emir E; Boxer GM; Qureshi U; Dearling JL; Robson MP; Begent RH; Trott KR; Pedley RB
    Clin Cancer Res; 2008 May; 14(9):2639-46. PubMed ID: 18451227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting and therapy of carcinoembryonic antigen-expressing tumors in transgenic mice with an antibody-interleukin 2 fusion protein.
    Xu X; Clarke P; Szalai G; Shively JE; Williams LE; Shyr Y; Shi E; Primus FJ
    Cancer Res; 2000 Aug; 60(16):4475-84. PubMed ID: 10969795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Intraportal injection of specific monoclonal antibody in nude mice with liver metastasis].
    Rivoire M; Yoshida K; Divgi C; Niedzwiecki D; Chapman D; Sigurdson E
    Chirurgie; 1990; 116(8-9):721-9. PubMed ID: 2129990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noninvasive visualization of tumor growth in a human colorectal liver metastases xenograft model using bioluminescence in vivo imaging.
    Thalheimer A; Korb D; Bönicke L; Wiegering A; Mühling B; Schneider M; Koch S; Riedel SS; Germer CT; Beilhack A; Brändlein S; Otto C
    J Surg Res; 2013 Nov; 185(1):143-51. PubMed ID: 23998649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a streptavidin-anti-carcinoembryonic antigen antibody, radiolabeled biotin pretargeting method for radioimmunotherapy of colorectal cancer. Studies in a human colon cancer xenograft model.
    Sharkey RM; Karacay H; Griffiths GL; Behr TM; Blumenthal RD; Mattes MJ; Hansen HJ; Goldenberg DM
    Bioconjug Chem; 1997; 8(4):595-604. PubMed ID: 9258460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor cell dissemination in a human colon cancer animal model: orthotopic implantation or intraportal injection?
    Thalheimer A; Otto C; Bueter M; Illert B; Gattenlohner S; Gasser M; Fein M; Germer CT; Waaga-Gasser AM
    Eur Surg Res; 2009; 42(3):195-200. PubMed ID: 19270457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pilot trial evaluating an 123I-labeled 80-kilodalton engineered anticarcinoembryonic antigen antibody fragment (cT84.66 minibody) in patients with colorectal cancer.
    Wong JY; Chu DZ; Williams LE; Yamauchi DM; Ikle DN; Kwok CS; Liu A; Wilczynski S; Colcher D; Yazaki PJ; Shively JE; Wu AM; Raubitschek AA
    Clin Cancer Res; 2004 Aug; 10(15):5014-21. PubMed ID: 15297402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted therapy of athymic mice bearing GW-39 human colonic cancer micrometastases with 131I-labeled monoclonal antibodies.
    Blumenthal RD; Sharkey RM; Haywood L; Natale AM; Wong GY; Siegel JA; Kennel SJ; Goldenberg DM
    Cancer Res; 1992 Nov; 52(21):6036-44. PubMed ID: 1394228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Influence of combination of low dosage 131I-labeled anti-carcinoembryonic antigen antibody C50 and 5-fluorouracil on tumor growth of colorectal cancer xenografts in nude mice].
    Zheng CX; Zhan WH; Cai SR; He YL; Lin ZJ
    Ai Zheng; 2003 Apr; 22(4):354-7. PubMed ID: 12703987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of bioluminescence imaging of colorectal liver metastases in the mouse.
    Smakman N; Martens A; Kranenburg O; Borel Rinkes IH
    J Surg Res; 2004 Dec; 122(2):225-30. PubMed ID: 15555622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of tumor targeting in nude mice by murine monoclonal antibodies directed against different human colorectal cancer antigens.
    Sharkey RM; Gold DV; Aninipot R; Vagg R; Ballance C; Newman ES; Ostella F; Hansen HJ; Goldenberg DM
    Cancer Res; 1990 Feb; 50(3 Suppl):828s-834s. PubMed ID: 2297729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of in vivo bioluminescence imaging to predict hepatic tumor burden in mice.
    Sarraf-Yazdi S; Mi J; Dewhirst MW; Clary BM
    J Surg Res; 2004 Aug; 120(2):249-55. PubMed ID: 15234220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical evaluation of indium-111-labeled chimeric anti-CEA monoclonal antibody.
    Wong JY; Thomas GE; Yamauchi D; Williams LE; Odom-Maryon TL; Liu A; Esteban JM; Neumaier M; Dresse S; Wu AM; Primus FJ; Shively JE; Raubitschek AA
    J Nucl Med; 1997 Dec; 38(12):1951-9. PubMed ID: 9430476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase I radioimmunotherapy trial evaluating 90yttrium-labeled anti-carcinoembryonic antigen (CEA) chimeric T84.66 in patients with metastatic CEA-producing malignancies.
    Wong JYC ; Chu DZ; Yamauchi DM; Williams LE; Liu A; Wilczynski S; Wu AM; Shively JE; Doroshow JH; Raubitschek AA
    Clin Cancer Res; 2000 Oct; 6(10):3855-63. PubMed ID: 11051230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cure of metastatic human colonic cancer in mice with radiolabeled monoclonal antibody fragments.
    Behr TM; Blumenthal RD; Memtsoudis S; Sharkey RM; Gratz S; Becker W; Goldenberg DM
    Clin Cancer Res; 2000 Dec; 6(12):4900-7. PubMed ID: 11156250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Experimental liver metastases of human colonic cancer: correlation with degree of differentiation and CEA production].
    Wagner HE; Steele GD; Thomas P
    Helv Chir Acta; 1992 Mar; 58(5):759-61. PubMed ID: 1592651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Initial experience evaluating 90yttrium-radiolabeled anti-carcinoembryonic antigen chimeric T84.66 in a phase I radioimmunotherapy trial.
    Wong JY; Williams LE; Yamauchi DM; Odom-Maryon T; Esteban JM; Neumaier M; Wu AM; Johnson DK; Primus FJ; Shively JE
    Cancer Res; 1995 Dec; 55(23 Suppl):5929s-5934s. PubMed ID: 7493373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined radioimmunotherapy and radiotherapy of liver metastases from colorectal cancer: a feasibility study.
    Buchegger F; Allal AS; Roth A; Papazyan JP; Dupertuis Y; Mirimanoff RO; Gillet M; Pelegrin A; Mach JP; Slosman DO
    Anticancer Res; 2000; 20(3B):1889-96. PubMed ID: 10928122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.